| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2014/02/15 | 01 : 35 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/17 | 08 : 35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/17 | 08 : 35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/17 | 08 : 34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/17 | 08 : 34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/17 | 08 : 34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/17 | 08 : 33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/17 | 08 : 33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/17 | 08 : 32 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/17 | 08 : 32 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/17 | 08 : 31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/17 | 08 : 31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/17 | 08 : 31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/15 | 05 : 30 | GlobeNewswire Inc. | Astex Pharmaceuticals to Present at AACR-NCI-EORTC | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/12 | 03 : 05 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/12 | 03 : 05 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/12 | 03 : 04 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/12 | 03 : 04 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/12 | 03 : 03 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/12 | 03 : 03 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/11 | 22 : 17 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/11 | 21 : 37 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/11 | 21 : 30 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/11 | 21 : 23 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/10 | 19 : 03 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/10 | 11 : 37 | GlobeNewswire Inc. | Astex Pharmaceuticals Responds to Further Misleading Claims Made by Sarissa Capital | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/10 | 06 : 27 | PR Newswire (US) | Sarissa Capital Highlights Advancement Of Astex Pipeline Compound | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/10 | 05 : 53 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/10 | 05 : 49 | PR Newswire (US) | Sarissa Capital Highlights Advancement Ofastex Pipeline Compound | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |
| 2013/10/09 | 05 : 19 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ASTX | Astex Pharmaceuticals, Inc. (MM) |